Aligarh, Feb. 5 -- impact biomedical innovation. The breakthrough has been achieved by Professor Sartaj Tabassum, in collaboration with Mr. Rijwan and Professor Farukh Arjmand, marking a decisive step forward in AMU's drug discovery efforts.
The patented molecule has exhibited robust in-vitro anticancer activity while maintaining low toxicity and cost-effectiveness, two attributes critical for translating laboratory research into accessible clinical solutions. Its promising performance positions the formulation as a strong candidate for further preclinical and clinical development, with the long-term potential to contribute to more affordable cancer therapies.
Professor Tabassum's research group is internationally recognised for its pione...